1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anti-inflammatory Biologics 1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 1.2.4 Corticosteroids 1.2.5 Others 1.3 Market by Application 1.3.1 Global Anti-inflammatory Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Arthritis 1.3.3 Respiratory Diseases 1.3.4 Dermatology 1.3.5 Gastroenterology 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-inflammatory Therapeutics Market Perspective (2016-2027) 2.2 Anti-inflammatory Therapeutics Growth Trends by Regions 2.2.1 Anti-inflammatory Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti-inflammatory Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Anti-inflammatory Therapeutics Industry Dynamic 2.3.1 Anti-inflammatory Therapeutics Market Trends 2.3.2 Anti-inflammatory Therapeutics Market Drivers 2.3.3 Anti-inflammatory Therapeutics Market Challenges 2.3.4 Anti-inflammatory Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue 3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue 3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio 3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2020 3.5 Anti-inflammatory Therapeutics Key Players Head office and Area Served 3.6 Key Players Anti-inflammatory Therapeutics Product Solution and Service 3.7 Date of Enter into Anti-inflammatory Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-inflammatory Therapeutics Breakdown Data by Type 4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2022-2027) 5 Anti-inflammatory Therapeutics Breakdown Data by Application 5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti-inflammatory Therapeutics Market Size (2016-2027) 6.2 North America Anti-inflammatory Therapeutics Market Size by Type 6.2.1 North America Anti-inflammatory Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Anti-inflammatory Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 6.3 North America Anti-inflammatory Therapeutics Market Size by Application 6.3.1 North America Anti-inflammatory Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Anti-inflammatory Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 6.4 North America Anti-inflammatory Therapeutics Market Size by Country 6.4.1 North America Anti-inflammatory Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Anti-inflammatory Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti-inflammatory Therapeutics Market Size (2016-2027) 7.2 Europe Anti-inflammatory Therapeutics Market Size by Type 7.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 7.3 Europe Anti-inflammatory Therapeutics Market Size by Application 7.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 7.4 Europe Anti-inflammatory Therapeutics Market Size by Country 7.4.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type 8.2.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application 8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region 8.4.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti-inflammatory Therapeutics Market Size (2016-2027) 9.2 Latin America Anti-inflammatory Therapeutics Market Size by Type 9.2.1 Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Anti-inflammatory Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Anti-inflammatory Therapeutics Market Size by Application 9.3.1 Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Anti-inflammatory Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country 9.4.1 Latin America Anti-inflammatory Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Anti-inflammatory Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type 10.2.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application 10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country 10.4.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction 11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.1.5 AbbVie Recent Development 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Details 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction 11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.2.5 Johnson & Johnson Recent Development 11.3 Amgen Inc 11.3.1 Amgen Inc Company Details 11.3.2 Amgen Inc Business Overview 11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction 11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.3.5 Amgen Inc Recent Development 11.4 AstraZeneca PLC 11.4.1 AstraZeneca PLC Company Details 11.4.2 AstraZeneca PLC Business Overview 11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction 11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.4.5 AstraZeneca PLC Recent Development 11.5 Pfizer, Inc 11.5.1 Pfizer, Inc Company Details 11.5.2 Pfizer, Inc Business Overview 11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction 11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.5.5 Pfizer, Inc Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Anti-inflammatory Therapeutics Introduction 11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.6.5 Novartis Recent Development 11.7 Roche 11.7.1 Roche Company Details 11.7.2 Roche Business Overview 11.7.3 Roche Anti-inflammatory Therapeutics Introduction 11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.7.5 Roche Recent Development 11.8 Merck 11.8.1 Merck Company Details 11.8.2 Merck Business Overview 11.8.3 Merck Anti-inflammatory Therapeutics Introduction 11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.8.5 Merck Recent Development 11.9 Sanofi 11.9.1 Sanofi Company Details 11.9.2 Sanofi Business Overview 11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction 11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.9.5 Sanofi Recent Development 11.10 GlaxoSmithKline 11.10.1 GlaxoSmithKline Company Details 11.10.2 GlaxoSmithKline Business Overview 11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction 11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.10.5 GlaxoSmithKline Recent Development 11.11 Sun Pharmaceutical Industries Ltd 11.11.1 Sun Pharmaceutical Industries Ltd Company Details 11.11.2 Sun Pharmaceutical Industries Ltd Business Overview 11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction 11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.11.5 Sun Pharmaceutical Industries Ltd Recent Development 11.12 TEVA 11.12.1 TEVA Company Details 11.12.2 TEVA Business Overview 11.12.3 TEVA Anti-inflammatory Therapeutics Introduction 11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2016-2021) 11.12.5 TEVA Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Anti-inflammatory Biologics Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Table 4. Key Players of Corticosteroids Table 5. Key Players of Others Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Anti-inflammatory Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Anti-inflammatory Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Anti-inflammatory Therapeutics Market Share by Regions (2016-2021) Table 10. Global Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Anti-inflammatory Therapeutics Market Share by Regions (2022-2027) Table 12. Anti-inflammatory Therapeutics Market Trends Table 13. Anti-inflammatory Therapeutics Market Drivers Table 14. Anti-inflammatory Therapeutics Market Challenges Table 15. Anti-inflammatory Therapeutics Market Restraints Table 16. Global Anti-inflammatory Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Anti-inflammatory Therapeutics Market Share by Players (2016-2021) Table 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2020) Table 19. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Anti-inflammatory Therapeutics Product Solution and Service Table 23. Date of Enter into Anti-inflammatory Therapeutics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2016-2021) Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Anti-inflammatory Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2016-2021) Table 31. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 63. AbbVie Company Details Table 64. AbbVie Business Overview Table 65. AbbVie Anti-inflammatory Therapeutics Product Table 66. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 67. AbbVie Recent Development Table 68. Johnson & Johnson Company Details Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Anti-inflammatory Therapeutics Product Table 71. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 72. Johnson & Johnson Recent Development Table 73. Amgen Inc Company Details Table 74. Amgen Inc Business Overview Table 75. Amgen Inc Anti-inflammatory Therapeutics Product Table 76. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 77. Amgen Inc Recent Development Table 78. AstraZeneca PLC Company Details Table 79. AstraZeneca PLC Business Overview Table 80. AstraZeneca PLC Anti-inflammatory Therapeutics Product Table 81. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 82. AstraZeneca PLC Recent Development Table 83. Pfizer, Inc Company Details Table 84. Pfizer, Inc Business Overview Table 85. Pfizer, Inc Anti-inflammatory Therapeutics Product Table 86. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 87. Pfizer, Inc Recent Development Table 88. Novartis Company Details Table 89. Novartis Business Overview Table 90. Novartis Anti-inflammatory Therapeutics Product Table 91. Novartis Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 92. Novartis Recent Development Table 93. Roche Company Details Table 94. Roche Business Overview Table 95. Roche Anti-inflammatory Therapeutics Product Table 96. Roche Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 97. Roche Recent Development Table 98. Merck Company Details Table 99. Merck Business Overview Table 100. Merck Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 101. Merck Recent Development Table 102. Sanofi Company Details Table 103. Sanofi Business Overview Table 104. Sanofi Anti-inflammatory Therapeutics Product Table 105. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 106. Sanofi Recent Development Table 107. GlaxoSmithKline Company Details Table 108. GlaxoSmithKline Business Overview Table 109. GlaxoSmithKline Anti-inflammatory Therapeutics Product Table 110. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 111. GlaxoSmithKline Recent Development Table 112. Sun Pharmaceutical Industries Ltd Company Details Table 113. Sun Pharmaceutical Industries Ltd Business Overview Table 114. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Table 115. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 116. Sun Pharmaceutical Industries Ltd Recent Development Table 117. TEVA Company Details Table 118. TEVA Business Overview Table 119. TEVA Anti-inflammatory Therapeutics Product Table 120. TEVA Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million) Table 121. TEVA Recent Development Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-inflammatory Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Anti-inflammatory Biologics Features Figure 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features Figure 4. Corticosteroids Features Figure 5. Others Features Figure 6. Global Anti-inflammatory Therapeutics Market Share by Application: 2020 VS 2027 Figure 7. Arthritis Case Studies Figure 8. Respiratory Diseases Case Studies Figure 9. Dermatology Case Studies Figure 10. Gastroenterology Case Studies Figure 11. Others Case Studies Figure 12. Anti-inflammatory Therapeutics Report Years Considered Figure 13. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Anti-inflammatory Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Anti-inflammatory Therapeutics Market Share by Regions: 2020 VS 2027 Figure 16. Global Anti-inflammatory Therapeutics Market Share by Regions (2022-2027) Figure 17. Global Anti-inflammatory Therapeutics Market Share by Players in 2020 Figure 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2020 Figure 20. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2016-2021) Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2022-2027) Figure 22. North America Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Anti-inflammatory Therapeutics Market Share by Type (2016-2027) Figure 24. North America Anti-inflammatory Therapeutics Market Share by Application (2016-2027) Figure 25. North America Anti-inflammatory Therapeutics Market Share by Country (2016-2027) Figure 26. United States Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Anti-inflammatory Therapeutics Market Share by Type (2016-2027) Figure 30. Europe Anti-inflammatory Therapeutics Market Share by Application (2016-2027) Figure 31. Europe Anti-inflammatory Therapeutics Market Share by Country (2016-2027) Figure 32. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Type (2016-2027) Figure 40. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Application (2016-2027) Figure 41. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Region (2016-2027) Figure 42. China Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Anti-inflammatory Therapeutics Market Share by Type (2016-2027) Figure 50. Latin America Anti-inflammatory Therapeutics Market Share by Application (2016-2027) Figure 51. Latin America Anti-inflammatory Therapeutics Market Share by Country (2016-2027) Figure 52. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Type (2016-2027) Figure 56. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Application (2016-2027) Figure 57. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2016-2027) Figure 58. Turkey Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 62. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 63. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 64. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 65. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 66. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 67. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 68. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 69. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 70. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 71. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 72. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

AbbVie Johnson & Johnson Amgen Inc AstraZeneca PLC Pfizer, Inc Novartis Roche Merck Sanofi GlaxoSmithKline Sun Pharmaceutical Industries Ltd TEVA